RELATIONSHIP OF ADIPONECTIN LEVEL WITH LIPID PROFILE IN TYPE-2 DIABETIC MEN WITH CORONARY HEART DISEASE

Insights

Serum adiponectin is significantly lower in type-2 diabetes patients with coronary heart disease (CHD). Low adiponectin correlates with poor lipid profiles, including high triglycerides and low HDL cholesterol, in these patients.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Diseases

Background:

  • Type-2 diabetes mellitus is a leading cause of long-term cerebrovascular complications.
  • Coronary heart disease (CHD) is a significant concern in diabetic populations.
  • Understanding the role of adiponectin and lipid profiles in diabetic CHD is crucial.

Purpose of the Study:

  • To determine serum adiponectin and lipid profile concentrations in type-2 diabetic men with CHD.
  • To investigate the relationship between adiponectin and lipid profiles in this cohort.
  • To compare these markers between diabetic patients with CHD and healthy individuals.

Main Methods:

  • A cross-sectional study involving 36 healthy males and 36 type-2 diabetic males with CHD.
  • Analysis of fasting blood samples for serum adiponectin, glucose, HbA1c, and lipid profile (TC, TG, HDL-C, LDL-C).
  • Pearson correlation coefficient (r) used to assess relationships between variables.

Main Results:

  • Diabetic men with CHD exhibited significantly lower serum adiponectin and HDL-C levels compared to healthy controls.
  • Elevated fasting blood glucose (FBG), HbA1c, total cholesterol (TC), triglycerides (TG), and LDL-C were observed in the diabetic CHD group.
  • Serum adiponectin showed a negative correlation with FBG, HbA1c, and TG, and a positive correlation with HDL-C in type-2 diabetic men with CHD.

Conclusions:

  • Serum adiponectin concentration is markedly reduced in type-2 diabetes patients with coronary heart disease.
  • Hypoadiponectinemia is associated with dyslipidemia, characterized by high TG and low HDL-C, in this population.
  • Adiponectin levels are positively associated with HDL-C and negatively with HbA1c and TG.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
861
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
994
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
592
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
854
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K